(Q45232445)

11 December 2017

title

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study (English)

1 reference

11 December 2017

1 reference

4

J Tuomilehto

1 reference

11 December 2017

5

K Borch-Johnsen

1 reference

11 December 2017

B Balkau

1

1 reference

11 December 2017

G Hu

2

1 reference

11 December 2017

Q Qiao

3

1 reference

11 December 2017

K Pyörälä

6

1 reference

11 December 2017

DECODE Study Group

7

1 reference

11 December 2017

European Diabetes Epidemiology Group

8

1 reference

11 December 2017

publication date

15 December 2004

1 reference

11 December 2017

1 reference

11 December 2017

volume

47

1 reference

11 December 2017

issue

12

1 reference

11 December 2017

page(s)

2118-2128

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-004-1574-5

11 December 2017

exact match

0 references

cites work

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-004-1574-5

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

12 December 2020

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

12 December 2020

The coronary profile: 12-year follow-up in the Framingham study

1 reference

12 December 2020

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

12 December 2020

The Framingham prediction rule is not valid in a European population of treated hypertensive patients

1 reference

12 December 2020

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

12 December 2020

Coronary heart disease risk assessment in diabetes mellitus--a comparison of PROCAM and Framingham risk assessment functions.

1 reference

12 December 2020

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

1 reference

12 December 2020

Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes

1 reference

12 December 2020

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

12 December 2020

Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure

1 reference

12 December 2020

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.

1 reference

12 December 2020

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

1 reference

12 December 2020

A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials

1 reference

12 December 2020

Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores.

1 reference

12 December 2020

Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association

1 reference

12 December 2020

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

1 reference

12 December 2020

Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop

1 reference

12 December 2020

Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

The Dundee coronary risk-disk for management of change in risk factors

1 reference

12 December 2020

Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men

1 reference

12 December 2020

Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study

1 reference

12 December 2020

Controlled trial of effect of documented cardiovascular risk scores on prescribing

1 reference

12 December 2020

Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application

1 reference

12 December 2020

Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study

1 reference

12 December 2020

Guidelines on preventing cardiovascular disease in clinical practice

1 reference

12 December 2020

Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study

1 reference

12 December 2020

A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study

1 reference

12 December 2020

Is there a glycemic threshold for mortality risk?

1 reference

12 December 2020

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

12 December 2020

Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts

1 reference

12 December 2020

European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by

1 reference

12 December 2020

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

12 December 2020

Prediction of coronary heart disease in Europe. The 2nd report of the WHO-ERICA Project. ERICA Research Group

1 reference

12 December 2020

10.1007/S00125-004-1574-5

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1011427923

0 references

1 reference